• About
    • Company Overview
    • Management Team
    • Board of Directors
    • Science Advisors
    • Neurology Advisors
    • Ophthalmology Advisors
    • Contacts
  • Science
    • Publications
    • Collaborators
  • Pipeline
    • Infantile Neuroaxonal Dystrophy (INAD)
    • Friedreich’s Ataxia (FA)
    • Amyotrophic Lateral Sclerosis (ALS)
    • Progressive Supranuclear Palsy (PSP)
    • Dry AMD
    • Future Targets
  • Patient Resources
    • Expanded Access Policy
    • Clinical Trials
    • Additional Resources
  • News & Events
    • Press Releases
    • News
    • Events
    • Videos
  • Careers
HomeScience AdvisorsCharles R. Cantor

Charles R. Cantor

Ph.D., Scientific Advisory Board Member

is a member of the US National Academy of Sciences (1988) and is currently on leave from Boston University (Professor of Biomedical Engineering and Director of the Center for Advanced Biotechnology). Founder and CSO (since 1998) of Sequenom, Inc. His main areas of expertise: biophysics, molecular genetics, molecular biology, genomics, bioinformatics.

His scientific interests include mass-spectrometry, prenatal diagnostics, in vivo RNA detection and epigenetics. He made important contributions to understanding of DNA-protein interactions and pioneered physical mapping of whole chromosomes. Invented (1984) and developed pulse field gel electrophoresis for analysis of very large DNA molecules.

He is also founder of SelectX Pharmaceuticals and DiThera. His copious awards include Eli Lilly Award in Biological Chemistry (1978), Biochemical Analysis Prize of the German Society of Clinical Chemistry (1988), ISCO Award for Advances in Biochemical Instrumentation (1989), H.A. Sober Award (American Society for Biochemistry and Molecular Biology, 1990), and E.M. Gray Award (Biophysical Society, 2000). (Co)authored several books (including the 3-volume textbook, Biophysical Chemistry) and more than 450 per-reviewed papers, as well as more than 60 patents.

He received his BA from Columbia University in 1963 and a Ph.D. from the University of California, Berkeley in 1966.

About
Science
  • Publications
Pipeline
  • Clinical
  • Preclinical
  • Future Targets
Patient Resources
  • Expanded Access Policy
News & Events
Careers
RETROTOPE, 4300 EL CAMINO REAL, SUITE 201, LOS ALTOS, CA 94022
Copyright ©️ 2015-2021 Retrotope Inc.
You are leaving Retrotope’s website. Retrotope does not guarantee the accuracy or completeness of the information contained on any third-party sites, nor does it endorse any of the opinions or information contained on those sites. Please click CONFIRM to continue. CONFIRM